How can biosimilars change the trajectory of breast cancer therapy?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)325-328
Number of pages4
JournalExpert Review of Anticancer Therapy
Volume20
Issue number5
DOIs
Publication statusPublished - May 3 2020

Keywords

  • Biosimilars
  • breast cancer
  • cancer policy
  • SBP
  • similar biotherapeutic products
  • trastuzumab
  • UHC

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this